Skip to main content
. 2017 Jan 23;32(1):106–114. doi: 10.3803/EnM.2017.32.1.106

Table 1. Baseline Characteristics of Subjects Who Underwent Thyroid Function Tests as Part of the Korea National Health and Nutrition Examination survey (2013 to 2015).

Characteristic Total sample Disease-free populationa Reference populationb
Total Male Female Total Male Female Total Male Female
No. of subjects 6,564 3,378 (52.8) 3,186 (47.2) 6,326 3,340 (54.4) 2,986 (45.6) 5,574 3,060 (56.4) 2,514 (43.6)
Age, yr 42 (28–56) 41 (26–54) 44 (29–58) 42 (27–55) 41 (26–54) 44 (28–57) 41 (26–55) 41 (26–54) 43 (27–57)
Age range, yr
 10–18 909 (13.8) 517 (15.3) 392 (12.3) 908 (14.4) 517 (15.5) 391 (13.1) 845 (15.2) 485 (15.8) 360 (14.3)
 19–29 1,106 (16.8) 566 (16.8) 540 (16.9) 1,098 (17.4) 563 (16.9) 535 (17.9) 981 (17.6) 520 (17.0) 461 (18.3)
 30–39 1,084 (16.5) 556 (16.5) 528 (16.6) 1,040 (16.4) 548 (16.4) 492 (16.5) 918 (16.5) 505 (16.5) 413 (16.4)
 40–49 1,101 (16.8) 569 (16.8) 532 (16.7) 1,045 (16.5) 562 (16.8) 483 (16.2) 907 (16.3) 515 (16.8) 392 (15.6)
 50–59 1,196 (18.2) 584 (17.3) 612 (19.2) 1,133 (17.9) 575 (17.2) 558 (18.7) 968 (17.4) 524 (17.1) 444 (17.7)
 60–69 1,058 (16.1) 527 (15.6) 531 (16.7) 997 (15.8) 518 (15.5) 479 (16.0) 860 (15.4) 460 (15.0) 400 (15.9)
 ≥70 110 (1.7) 59 (1.7) 51 (1.6) 105 (1.7) 57 (1.7) 48 (1.6) 95 (1.7) 51 (1.7) 44 (1.8)
Urinary iodine, µg/L 299.4 (158.9–700.1) 295.3 (167.1–673.7) 301.2 (150.8–747.6) 298.4 (159.1–694.4) 295.9 (167.3–674.6) 300.3 (150.4–730.2) 298.7 (160.1–692.0) 295.3 (168.8–669.7) 300.2 (150.8–736.1)
Urine iodine/Cr, µg/g 192.6 (103.2–477.6) 169.0 (92.2–379.4) 228.8 (120.0–595.5) 190.7 (102.2–466.4) 169.0 (92.2–378.9) 224.4 (117.7–571.8) 191.0 (101.6–459.3) 169.0 (92.3–374.0) 224.8 (116.6–571.8)
TPOAb positivityc 480 (7.3) 145 (4.3) 335 (10.5) 388 (5.3) 128 (3.8) 260 (8.7) NA NA NA
History of thyroid 169 (2.6) 26 (0.8) 143 (4.5) NA NA NA NA NA NA

Values are expressed as number (%) or median (interquartile range).

Cr, creatinine; TPOAb, anti-thyroid peroxidase antibody.

aThe disease-free population was defined as subjects with no prior history of thyroid disease and no history of taking medication that could influence thyroid function; bThe reference population was defined subjects with no prior history of thyroid disease, no history of taking medications that could influence thyroid function, no family history of thyroid disease, negative TPOAb results, and serum free thyroxine levels in the reference range (0.89 to 1.76 ng/dL); cTPOAb positivity was defined as >34.0 IU/mL.